SECOS’s proprietary resins used in responsible packaging
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
In a strategically important development, sustainable and eco-friendly bioplastics developer SECOS Group Ltd’s (ASX:SES) proprietary Cardia Bioplastics Compostable Resins have been used by a major South African packaging company to produce high-quality compostable bunch carry bags and carton liners as alternatives to single use plastics.
SECOS’s Cardia BF04 Resins are FDA (US Food and Drug Administration) compliant and safe for food contact applications, and its Cardia Resins are also certified compostable to AS4736, EN13432 and other international standards.
The new range of environmental products commonly used in the delivery of food products including grape bags and other fruit box liner products replaces single use plastics for food handling.
SECOS has received small quantity commercial orders and management is expecting demand to grow as sales of the product range expands.
Accelerated transition to responsible packaging
The packaging company is Superior Packaging Industries which has a prominent position in the South African plastics conversion industry, with the group producing film products which it prints, slits and laminates.
More recently, Superior Packaging has explored the domestic and export markets with its US range of fully compostable products with target markets in the food space being dairy, produce, food manufacturers and bakeries.
Highlighting the attractive characteristics of SECOS’s resins, Superior Packaging operations manager, Mark Williams said, “Cardia’s compostable resins met our strict requirements that ensure our products are made from renewable plant-based materials, are food safe and certified as such by US Food and Drug Administration and Din Certco certified as biodegradable and compostable as per EN13432 using only non-GMO certified raw materials.”
Underlining the increasing transition to responsible packaging, SECOS director of sales, Stephen Walters said, “It’s been very exciting working with Superior Packaging on the development of their new range of environmentally friendly products.
“Developments such as this show how innovative packaging companies can use Cardia resins to provide greater choice to their customers and support the shift to responsible environmental packaging solutions”
From a strategic perspective this is a particularly important development as food grade packaging has been identified as one of the company’s key markets and management expect further applications in this area.
Restructuring to result in improved earnings quality
SECOS holds a strong patent portfolio and the global trend toward sustainable packaging is fuelling the company’s growth.
The group’s headquarters and Global Application Development Centre are based in Melbourne, Australia, but SECOS also has a Product Development Centre and manufacturing plant for resins and finished products in Nanjing, China, with manufacturing plants for high quality cast films in Malaysia.
Recent group restructuring has resulted in improved manufacturing efficiencies and significant cost reductions for SECOS, translating into higher margins which could well see earnings growth proportionately outstrip the increases in revenues which should stem from increased product demand.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
